Arcus Biosciences Inc (RCUS) — Cash Flow Reinvestment Rate
Arcus Biosciences Inc (RCUS) has a Cash Flow Reinvestment Rate of 1.15x as of September 2024, reinvesting $30.00 Million (capex $1.00 Million plus investments $-29.00 Million) from operating cash flow of $26.00 Million. Check Arcus Biosciences Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Arcus Biosciences Inc Cash Flow Reinvestment Rate (2020–2022)
Historical reinvestment intensity for Arcus Biosciences Inc across 2 annual periods. Explore RCUS long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Arcus Biosciences Inc (2020–2022)
Year-by-year capital reinvestment analysis for Arcus Biosciences Inc. For live market cap and broader valuation context, see RCUS market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.96x | $419.00 Million | $438.00 Million | $6.00 Million | ▼ -75.5% |
| 2020 | 3.91x | $434.37 Million | $111.17 Million | $3.06 Million | — |